Swiss National Bank
DTIL icon

Swiss National Bank’s Precision BioSciences DTIL Stock Holding History

Swiss National Bank’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,830
Closed -$354K – 2759
2022
Q1 		$354K Buy
3,830
+333
+10% +$45.2K ﹤0.01% 2646
2021
Q4 		$776K Buy
3,497
+137
+4% +$38.3K ﹤0.01% 2559
2021
Q3 		$1.16M Hold
3,360
– – ﹤0.01% 2362
2021
Q2 		$1.26M Buy
3,360
+600
+22% +$180K ﹤0.01% 2367
2021
Q1 		$857K Hold
2,760
– – ﹤0.01% 2382
2020
Q4 		$691K Buy
2,760
+83
+3% +$20.3K ﹤0.01% 2414
2020
Q3 		$495K Hold
2,677
– – ﹤0.01% 2362
2020
Q2 		$669K Buy
+2,677
New +$586K ﹤0.01% 2296

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Swiss National Bank's DTIL Position: Q2 2022 in Review

Swiss National Bank sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 3,830 shares — an estimated $354K sold.

Swiss National Bank first reported a position in DTIL in Q2 2020 and held it in 8 quarters. The position peaked at $1.26M in Q2 2021. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

  • Swiss National Bank reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
  • Swiss National Bank sold 3,830 Precision BioSciences shares in Q2 2022, an estimated $354K.
  • Swiss National Bank first reported a position in Precision BioSciences in Q2 2020 and held it in 8 quarters.
  • Swiss National Bank's Precision BioSciences position peaked at $1.26M in Q2 2021.
  • 119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.